PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
26-Sep-2024 PharmaCord Announces Completion of Permira Investment Newswire
25-Sep-2024 Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US Newswire
25-Sep-2024 GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis Newswire
25-Sep-2024 Explosive Growth in 3D Imaging Market Driven by Advancements in Healthcare and Industrial Applications Acumen Research And Consulting
25-Sep-2024 Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call Newswire
24-Sep-2024 Phastar Announced as 2024 Scrip Award Finalist for Best Contract Research Organization – Specialist Provider Phastar
24-Sep-2024 Digital Therapeutics Market To Witness Explosive Growth of Around 29% CAGR from 2023 to 2032 Driven By Widespread Adoption of Digital Health Solutions Acumen Research And Consulting
24-Sep-2024 Enalare Receives FDA Clearance to Initiate the First Phase 1 Clinical Study of ENA-001 to Be Conducted in the United States Newswire
24-Sep-2024 Longwood Healthcare Leaders' Flagship Meeting Boston CEO to Convene Life Science Thought Leaders Across Government, Pharma, Biotech, Academia, and Research Newswire
24-Sep-2024 ZEO ScientifiX is Moving Toward Its Goal of Transforming Healthcare Through Leading-Edge Research Newswire
23-Sep-2024 DARZALEX® (daratumumab)-based quadruplet regimen receives positive CHMP opinion for transplant-eligible patients with newly diagnosed multiple myeloma Janssen-Cilag
23-Sep-2024 Almirall to present new data on biologics for psoriasis and atopic dermatitis and celebrates 80 years of innovation at the EADV congress Almirall
23-Sep-2024 Apprentice.io Announces New AI-Powered Capabilities at European Pharma Event and Offers a Free Trial of Its Tempo Manufacturing Cloud Newswire
19-Sep-2024 Aston Institute for Membrane Excellence celebrates official launch with multidisciplinary event Aston University
19-Sep-2024 Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer Autolus Therapeutics plc
19-Sep-2024 Ketabon To Present Advancements In At-Home Ketamine Therapy For Treatment-Resistant Depression At ECNP Congress 2024 Ketabon GmbH
19-Sep-2024 OEAW AND BOEHRINGER INGELHEIM FOUNDATION ESTABLISH NEW INSTITUTE FOR BIOMEDICAL ARTI-FICIAL INTELLIGENCE IN VIENNA Boehringer Ingelheim
19-Sep-2024 MHRA grants Benilexa® One Handed (52mg levonorgestrel intrauterine system [IUS]) an 8-year licence for contraception in the UK Gedeon Richter UK Ltd
18-Sep-2024 New Hope for Mpox? How TNX-801 Could Meet the WHO's Vaccine Targets for a Safer, Single-Dose Solution Newswire
18-Sep-2024 Faro Health Joins Veeva Product Partner Program Newswire